Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Obstructive Lung Diseases

  Free Subscription


26.10.2026

1 Am J Respir Crit Care Med
2 Ann Allergy Asthma Immunol
1 Arch Dis Child
1 Chest
1 Eur Respir J
2 J Allergy Clin Immunol
11 J Asthma
1 J Investig Allergol Clin Immunol
1 PLoS One
20 Respir Med
4 Respir Res


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Respir Crit Care Med

  1. QU HQ, Qiu H, Mentch FD, Cardinale CJ, et al
    Cross-Ancestry Analysis of the 1q31 Th2-Associated Interval in Steroid-Dependent Asthma.
    Am J Respir Crit Care Med. 2026 Oct 20:aamag549. doi: 10.1093.
    PubMed        


    Ann Allergy Asthma Immunol

  2. YILDIRIM R, Tuzen HI, Yildirim PA, Yigit ES, et al
    Nailfold capillary alterations in pediatric asthma: evidence of peripheral microvascular involvement.
    Ann Allergy Asthma Immunol. 2026 Oct 23:S1081-1206(26)01304.
    PubMed         Abstract available

  3. MENDOZA LE, Schomberg J, Galant SP
    FeNO-Guided Care Improves Asthma Control in Atopic and Non-Atopic Underserved Hispanic/Latino Children.
    Ann Allergy Asthma Immunol. 2026 Oct 22:S1081-1206(26)01307.
    PubMed        


    Arch Dis Child

  4. RUFFLES T, Youssef E, Holden C, Haeffner A, et al
    Feasibility of a personalised medicine clinic for children with asthma: the PRISTINE 2 study.
    Arch Dis Child. 2026 Oct 20:archdischild-2026-330582.
    PubMed        


    Chest

  5. BOEHM-COHEN L, Pollock J, Kompatsiari E, Blumenfeld Z, et al
    Fertility, pregnancy, and women's health in bronchiectasis: a multicenter study and ELF-EMBARC patient survey.
    Chest. 2026 Oct 19:S0012-3692(26)06889-3. doi: 10.1016/j.chest.2026.
    PubMed         Abstract available


    Eur Respir J

  6. BUSSE WW, Jackson DJ
    Are lung function measurements necessary to evaluate efficacy of biologics in asthma?
    Eur Respir J. 2026;68:2601480.
    PubMed        


    J Allergy Clin Immunol

  7. CHAN R, Pippard BJ, Fahy JV
    Beyond the airways: expiratory pulmonary vascular retention and reduced compressibility in asthma.
    J Allergy Clin Immunol. 2026 Oct 20:S0091-6749(26)00719.
    PubMed        

  8. KARP T, Faiz A, Kerstjens HAM, Nawijn MC, et al
    Accounting for seasonal variation of nasal gene expression improves transcriptome analysis of asthma.
    J Allergy Clin Immunol. 2026 Oct 17:S0091-6749(26)00721.
    PubMed         Abstract available


    J Asthma

  9. GONEHGAR MR, Sharif Shoushtari M, Ghobadzadeh S, Ghorbanzade K, et al
    Geographic patterns of asthma morbidity: a systematic review of Sand and dust storm (SDS) impacts in Asia.
    J Asthma. 2026 Oct 19:1-13. doi: 10.1080/02770903.2026.2751845.
    PubMed         Abstract available

  10. THEKKINKATTIL M, Katiyar S, Gopal B, Saha A, et al
    A Prospective Observational Real-World Study to Assess the Effectiveness and Safety of Single-Inhaler Triple Therapy with Glycopyrrolate/Formoterol Fumarate/Budesonide in Patients with Uncontrolled Asthma.
    J Asthma. 2026 Oct 17:1-12. doi: 10.1080/02770903.2026.2751842.
    PubMed         Abstract available

  11. UL ABIDEEN Z, Ashraf MF, Javed S, Khalid L, et al
    Safety and Efficacy of Albuterol-Budesonide Versus Albuterol Alone in Asthma: A GRADE-assessed Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    J Asthma. 2026 Oct 19:1-14. doi: 10.1080/02770903.2026.2751840.
    PubMed         Abstract available

  12. BUENDIA JA
    Changing Patterns of Diagnostic Testing in Children With Asthma: Evidence of Redistribution, Overuse, and Recovery After the COVID-19 Pandemic.
    J Asthma. 2026 Oct 19:1-15. doi: 10.1080/02770903.2026.2751830.
    PubMed         Abstract available

  13. COOKE L, Noble N, Bryant J, Curtis J, et al
    Parent perspectives on the potential use of smart inhalers for asthma management in children: a qualitative interview study.
    J Asthma. 2026 Oct 19:1-15. doi: 10.1080/02770903.2026.2751829.
    PubMed         Abstract available

  14. CHENXIA D, Shao Z, Zhan L, Shen D, et al
    METTL3 destabilizes RFX7 to ameliorate PDGF-BB-induced airway smooth muscle cell dysfunction and inflammation in an in vitro model of childhood asthma.
    J Asthma. 2026 Oct 20:1-13. doi: 10.1080/02770903.2026.2751839.
    PubMed         Abstract available

  15. ZHANG S, Li X, Choi DH, Desai S, et al
    Usability, educational engagement, and patient-reported outcomes in a mobile asthma intervention.
    J Asthma. 2026 Oct 20:1-15. doi: 10.1080/02770903.2026.2751846.
    PubMed         Abstract available

  16. SRIVALI N, Giacomi F
    Planned biologic discontinuation in severe asthma: a systematic review and meta-analysis.
    J Asthma. 2026 Oct 22:1-15. doi: 10.1080/02770903.2026.2751835.
    PubMed         Abstract available

  17. PATEL D, Tamakuwala G, Patel S
    Association Between Serum Magnesium Status and Bronchial Asthma Severity: A Gender-Matched Retrospective Cohort Study.
    J Asthma. 2026 Oct 21:1-14. doi: 10.1080/02770903.2026.2751847.
    PubMed         Abstract available

  18. ALSUFYANI A, Saaty L, Mansur A Professor
    The Effect of Nasal Corticosteroids and Antihistamines on Asthma Control in Patients with Asthma and Comorbid Allergic Rhinitis: A Systematic Review.
    J Asthma. 2026 Oct 21:1-24. doi: 10.1080/02770903.2026.2751828.
    PubMed         Abstract available

  19. AL-QEREM W, Jarab A, Al Bawab AQ, Eberhardt J, et al
    The association between parental health numeracy and medication adherence among children with asthma in Jordan: A cross-sectional study.
    J Asthma. 2026 Oct 22:1-21. doi: 10.1080/02770903.2026.2751850.
    PubMed         Abstract available


    J Investig Allergol Clin Immunol

  20. MIRALLES-LOPEZ JC, Garcia-Moguel I, Habernau-Mena A, Rial-Prado MJ, et al
    Positioning of Depemokimab in Uncontrolled Severe Asthma.
    J Investig Allergol Clin Immunol. 2026 Oct 19:0. doi: 10.18176/jiaci.1229.
    PubMed         Abstract available


    PLoS One

  21. MAZURIK K, Marciniuk DD, Penz E, Comfort P, et al
    Protocol for a realist evaluation of a COPD clinical pathway in Saskatchewan, Canada.
    PLoS One. 2026;21:e0359299.
    PubMed         Abstract available


    Respir Med

  22. NGUYEN K, Hazlitt R, Jones G, Hemmerich C, et al
    Equity in Asthma Research: A Meta-Analysis on Participant Diversity in U.S. Clinical Trials.
    Respir Med. 2026 Oct 23:109234. doi: 10.1016/j.rmed.2026.109234.
    PubMed         Abstract available

  23. BACKLIN E, Breznik E, Smedby O, Skold M, et al
    Added value of expiratory CT in chronic airflow limitation.
    Respir Med. 2026;263:109098.
    PubMed         Abstract available

  24. KONDAMEDA R, Kolliputi S, Kolliputi N
    COPD and osteoporosis: Epidemiology, pathophysiology, clinical impact, and management strategies: A narrative review.
    Respir Med. 2026;263:109126.
    PubMed         Abstract available

  25. LOHANA AC, Akbar UA, Chander S, Sorath FNU, et al
    Osteoporosis and its clinical burden in chronic obstructive pulmonary disease: A retrospective cohort study.
    Respir Med. 2026;263:109129.
    PubMed         Abstract available

  26. SINGH O, Adarsh, Mishra MK, Patel Y, et al
    Longitudinal assessment of symptom distress and its association with disease severity among patients with chronic obstructive pulmonary disease: A prospective observational study.
    Respir Med. 2026;263:109133.
    PubMed         Abstract available

  27. PATELLA V, Nicoletta C, Ferrara F, Inglese O, et al
    IL-5 biology and eosinophil regulation: Advances, resistance pathways and future directions.
    Respir Med. 2026;263:109132.
    PubMed         Abstract available

  28. LEE S, Shin GY, Jung JY, Park J, et al
    Automated three-dimensional diaphragm-related surface morphometry from paired chest CT in chronic obstructive pulmonary disease.
    Respir Med. 2026;263:109139.
    PubMed         Abstract available

  29. FERNANDEZ-FERNANDEZ S, Hernansanz AN, Ortiz C, Lopez-Cuadrado T, et al
    Determinants of sustained smoking among individuals with chronic respiratory diseases and effects on all-cause mortality: a population-based study.
    Respir Med. 2026;263:109149.
    PubMed         Abstract available

  30. SUN Y, Li J, Liu Z, Huang J, et al
    Spirometric impairment and incident cardiovascular disease: Beyond airflow limitation.
    Respir Med. 2026;263:109160.
    PubMed         Abstract available

  31. ZHANG J, Bertels X, Xu H, Gereige JD, et al
    Cluster analysis of obstructive lung disease phenotypes: the Framingham heart study and the Rotterdam study.
    Respir Med. 2026;263:109161.
    PubMed         Abstract available

  32. CANDIA C, Komici K, Fuschillo S, Ambrosino P, et al
    Physical inactivity in COPD: a key determinant of frailty and adverse outcomes.
    Respir Med. 2026;263:109177.
    PubMed         Abstract available

  33. BETANCOR D, Villalobos-Violan V, Antolin-Amerigo D, De Las Vecillas L, et al
    Tezepelumab effectiveness in aspirin-exacerbated respiratory disease: a real-world multicenter study.
    Respir Med. 2026;263:109178.
    PubMed         Abstract available

  34. XU J, Chen Q, Zhang B, Meng R, et al
    Early cardiovascular vulnerability after acute exacerbation of COPD: a time-windowed systematic review and evidence map.
    Respir Med. 2026;263:109181.
    PubMed         Abstract available

  35. PORTO EF, da Silva GME, Shimizu Gaspar HH, Camargo GG, et al
    Effects of pulmonary rehabilitation on lung hyperinflation in patients with COPD: A systematic review and meta-analysis.
    Respir Med. 2026;263:109172.
    PubMed         Abstract available

  36. HAMANN KM, Wendt CH, Baldomero AK
    Sex differences in delivery of guideline-recommended COPD care: A national U.S. cohort.
    Respir Med. 2026;263:109196.
    PubMed         Abstract available

  37. ROGLIANI P, Brusselle G, Stolz D, Piraino A, et al
    Early versus late escalation to extrafine BDP/FF/GB single-inhaler triple therapy in COPD: a real-world subgroup analysis by disease duration since diagnosis.
    Respir Med. 2026;263:109195.
    PubMed         Abstract available

  38. WANG S, Azimbagirad M, Cheng DO, Patrick T, et al
    Pulmonary arterial volume and mortality in smokers without chronic obstructive pulmonary disease.
    Respir Med. 2026;263:109134.
    PubMed         Abstract available

  39. SANTIWORAKUL A, Cetthakrikul S, Nemoto S, Nakabo T, et al
    Effects of complementary therapies on physiological and psychological outcomes in chronic obstructive pulmonary disease patients: A systematic review and meta-analysis of randomized controlled trials.
    Respir Med. 2026;263:109204.
    PubMed         Abstract available

  40. AJAZ M, Singh I, Vugic L, Jani R, et al
    The association between New Zealand Blackcurrant anthocyanins and airway inflammation, including PAI-1, in asthma: A placebo-controlled crossover feasibility study.
    Respir Med. 2026;264:109222.
    PubMed         Abstract available

  41. GIOVANNELLI J, Perez T, Garcia G, Devouassoux G, et al
    Prevalence and factors associated with exertional dyspnea in severe asthma: data at inclusion from the French RAMSES cohort.
    Respir Med. 2026;264:109239.
    PubMed         Abstract available


    Respir Res

  42. HE M, Zhao Q, Xie H, Zhang R, et al
    Clinical, radiological, and pathological features of pulmonary hypertension associated with combined pulmonary fibrosis and emphysema.
    Respir Res. 2026;27:417.
    PubMed         Abstract available

  43. HUANG X, Qu F, Luo Q, Li Y, et al
    Single?cell and spatial transcriptomics in chronic lung disease: cellular heterogeneity and molecular mechanisms in IPF and COPD.
    Respir Res. 2026;27:413.
    PubMed         Abstract available

  44. ZHU H, Zhou X, Xiang L, Yang Z, et al
    Technical safety and efficacy of PFA catheter electrode for airway ablation in a rat model of COPD.
    Respir Res. 2026;27:411.
    PubMed         Abstract available

  45. LIU Y, Yi E, Xi Y, Zuo Y, et al
    A novel protective role for SULF1 in chronic obstructive pulmonary disease through systemic compensation and binding to KRT15.
    Respir Res. 2026;27:410.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Obstructive Lung Diseases is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum